Clinical Trial Management Market by Delivery Mode, Product Type, Component, and End Users : Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4580624
  • Report
  • Region: Global
  • 214 pages
  • Allied Analytics LLP
1 of 4
The global clinical trial management market was valued at $570 million in 2016, and is estimated to reach $1,371 million by 2023, registering a CAGR of 13.4% from 2017 to 2023. Clinical trial management system (CTMS) is a software used for managing clinical trials of usually biotechnology and pharmaceutical industries. The high efficiency of the system to maintain & manage plans, perform & report functions, as well as store participant contact information, and track deadlines boost the market growth.

Increase in adoption of clinical trial management system (CTMS) in clinical trials, growth in the number of clinical trials, increase in trend of outsourcing of clinical trials, favorable government initiatives supporting the use of CTMS, and increase in awareness regarding the benefits of using CTM. However, dearth of skilled professionals to operate advanced CTMS solutions and high cost and data security issue of CTMS solutions restrain the market growth. Conversely, rise in R&D activities and expenditure of pharmaceutical and bio-pharmaceutical companies provides lucrative opportunities for the market growth.

The global clinical trials management system market is segmented based on product type, component, delivery mode, end user, and region. Based on product, it is bifurcated into enterprise-based and site-based. Based on the component, it is divided into hardware, software, and services. Based on mode of delivery, it is categorized into web-based CTMS, on-premise, and cloud-based CTMS. Based on end user, it is classified into pharmaceutical & biopharmaceutical companies, clinical research organizations, and healthcare providers. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STAKEHOLDERS

This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on region facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Delivery Mode

Web-based CTMS
On-premise
Cloud-based CTMS

By Product Type

Enterprise-based
Site-based

By Component

Software
Hardware
Services

By End Users

Pharmaceutical and Biopharmaceutical Companies
Clinical Research Organizations
Healthcare Providers

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

KEY PLAYERS PROFILED

Oracle
Medidata Solutions
Parexel
BioClinica, Inc.
Bio-Optronics
IBM
MedNet Solutions
Veeva Systems
Forte Research Systems
Merge Healthcare Incorporated

The other players of the Clinical Trial Management market include (companies not profiled in the report):

Mednet Solutions
Arisglobal
eClinForce Inc.
DZS Software Solutions
DSG, Inc.
Guger Technologies Inc.
ICON, Plc.
ChemWare Inc.
iWeb Technologies Limited
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key findings
3.2.1. Top Investment Pockets
3.3. Top player positioning, 2016
3.4. Porters five forces analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Rise in the number of clinical trials
3.5.1.2. Increase in trend of outsourcing of clinical trials
3.5.1.3. Increase in prevalence of chronic diseases
3.5.1.4. Increase in awareness regarding the benefits of using CTM
3.5.2. Restrains
3.5.2.1. High cost and data security issues
3.5.2.2. Dearth of qualified and skilled healthcare professionals
3.5.3. Opportunities
3.5.3.1. Increase in R&D activities and expenditure to implement CTM

CHAPTER 4: CLINICAL TRIAL MANAGEMENT MARKET BY DELIVERY MODE
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Web-based
4.2.1. Key market trends & growth opportunities
4.2.2. Market Size and Forecast
4.2.3. Market Analysis, by Country
4.3. On-premise
4.3.1. Key market trends & growth opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
4.4. Cloud-based
4.4.1. Key market trends & growth opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country

CHAPTER 5: CLINICAL TRIAL MANAGEMENT MARKET BY PRODUCT TYPE
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Enterprise-based CTM
5.2.1. Market Size and Forecast
5.2.2. Market Analysis, by Country
5.3. Site-based
5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country

CHAPTER 6: CLINICAL TRIAL MANAGEMENT MARKET BY COMPONENT
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Software
6.2.1. Market Size and Forecast
6.2.2. Market Analysis, by Country
6.3. Hardware
6.3.1. Market Size and Forecast
6.3.2. Market Analysis, by Country
6.4. Services
6.4.1. Market Size and Forecast
6.4.2. Market Analysis, by Country

CHAPTER 7: CLINICAL TRIAL MANAGEMENT MARKET BY END USERS
7.1. Overview
7.1.1. Market Size and Forecast
7.2. Pharmaceutical and Biopharmaceutical Companies
7.2.1. Market Size and Forecast
7.2.2. Market Analysis, by Country
7.3. Clinical Research Organizations
7.3.1. Market Size and Forecast
7.3.2. Market Analysis, by Country
7.4. Healthcare Providers
7.4.1. Market Size and Forecast
7.4.2. Market Analysis, by Country

CHAPTER 8: CLINICAL TRIAL MANAGEMENT MARKET BY REGION
8.1. Overview
8.1.1. Market Size and Forecast
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, by Product Type
8.2.3. Market Size and Forecast, by Delivery Mode
8.2.4. Market Size and Forecast, by Component
8.2.5. Market Size and Forecast, by End Users
8.2.6. Market Size and Forecast, by Country
8.2.6.1. U.S. Market Size and Forecast, by Product Type
8.2.6.2. U.S. Market Size and Forecast, by Delivery Mode
8.2.6.3. U.S. Market Size and Forecast, by Component
8.2.6.4. U.S. Market Size and Forecast, by End Users
8.2.6.5. Canada Market Size and Forecast, by Product Type
8.2.6.6. Canada Market Size and Forecast, by Delivery Mode
8.2.6.7. Canada Market Size and Forecast, by Component
8.2.6.8. Canada Market Size and Forecast, by End Users
8.2.6.9. Mexico Market Size and Forecast, by Product Type
8.2.6.10. Mexico Market Size and Forecast, by Delivery Mode
8.2.6.11. Mexico Market Size and Forecast, by Component
8.2.6.12. Mexico Market Size and Forecast, by End Users
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, by Product Type
8.3.3. Market Size and Forecast, by Delivery Mode
8.3.4. Market Size and Forecast, by Component
8.3.5. Market Size and Forecast, by End Users
8.3.6. Market Size and Forecast, by Country
8.3.6.1. Germany Market Size and Forecast, by Product Type
8.3.6.2. Germany Market Size and Forecast, by Delivery Mode
8.3.6.3. Germany Market Size and Forecast, by Component
8.3.6.4. Germany Market Size and Forecast, by End Users
8.3.6.5. France Market Size and Forecast, by Product Type
8.3.6.6. France Market Size and Forecast, by Delivery Mode
8.3.6.7. France Market Size and Forecast, by Component
8.3.6.8. France Market Size and Forecast, by End Users
8.3.6.9. UK Market Size and Forecast, by Product Type
8.3.6.10. UK Market Size and Forecast, by Delivery Mode
8.3.6.11. UK Market Size and Forecast, by Component
8.3.6.12. UK Market Size and Forecast, by End Users
8.3.6.13. Italy Market Size and Forecast, by Product Type
8.3.6.14. Italy Market Size and Forecast, by Delivery Mode
8.3.6.15. Italy Market Size and Forecast, by Component
8.3.6.16. Italy Market Size and Forecast, by End Users
8.3.6.17. Spain Market Size and Forecast, by Product Type
8.3.6.18. Spain Market Size and Forecast, by Delivery Mode
8.3.6.19. Spain Market Size and Forecast, by Component
8.3.6.20. Spain Market Size and Forecast, by End Users
8.3.6.21. Rest of Europe Market Size and Forecast, by Product Type
8.3.6.22. Rest of Europe Market Size and Forecast, by Delivery Mode
8.3.6.23. Rest of Europe Market Size and Forecast, by Component
8.3.6.24. Rest of Europe Market Size and Forecast, by End Users
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, by Product Type
8.4.3. Market Size and Forecast, by Delivery Mode
8.4.4. Market Size and Forecast, by Component
8.4.5. Market Size and Forecast, by End Users
8.4.6. Market Size and Forecast, by Country
8.4.6.1. Japan Market Size and Forecast, by Product Type
8.4.6.2. Japan Market Size and Forecast, by Delivery Mode
8.4.6.3. Japan Market Size and Forecast, by Component
8.4.6.4. Japan Market Size and Forecast, by End Users
8.4.6.5. China Market Size and Forecast, by Product Type
8.4.6.6. China Market Size and Forecast, by Delivery Mode
8.4.6.7. China Market Size and Forecast, by Component
8.4.6.8. China Market Size and Forecast, by End Users
8.4.6.9. Australia Market Size and Forecast, by Product Type
8.4.6.10. Australia Market Size and Forecast, by Delivery Mode
8.4.6.11. Australia Market Size and Forecast, by Component
8.4.6.12. Australia Market Size and Forecast, by End Users
8.4.6.13. India Market Size and Forecast, by Product Type
8.4.6.14. India Market Size and Forecast, by Delivery Mode
8.4.6.15. India Market Size and Forecast, by Component
8.4.6.16. India Market Size and Forecast, by End Users
8.4.6.17. South Korea Market Size and Forecast, by Product Type
8.4.6.18. South Korea Market Size and Forecast, by Delivery Mode
8.4.6.19. South Korea Market Size and Forecast, by Component
8.4.6.20. South Korea Market Size and Forecast, by End Users
8.4.6.21. Rest of Asia-Pacific Market Size and Forecast, by Product Type
8.4.6.22. Rest of Asia-Pacific Market Size and Forecast, by Delivery Mode
8.4.6.23. Rest of Asia-Pacific Market Size and Forecast, by Component
8.4.6.24. Rest of Asia-Pacific Market Size and Forecast, by End Users
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, by Product Type
8.5.3. Market Size and Forecast, by Delivery Mode
8.5.4. Market Size and Forecast, by Component
8.5.5. Market Size and Forecast, by End Users
8.5.6. Market Size and Forecast, by Country
8.5.6.1. Brazil Market Size and Forecast, by Product Type
8.5.6.2. Brazil Market Size and Forecast, by Delivery Mode
8.5.6.3. Brazil Market Size and Forecast, by Component
8.5.6.4. Brazil Market Size and Forecast, by End Users
8.5.6.5. Saudi Arabia Market Size and Forecast, by Product Type
8.5.6.6. Saudi Arabia Market Size and Forecast, by Delivery Mode
8.5.6.7. Saudi Arabia Market Size and Forecast, by Component
8.5.6.8. Saudi Arabia Market Size and Forecast, by End Users
8.5.6.9. South Africa Market Size and Forecast, by Product Type
8.5.6.10. South Africa Market Size and Forecast, by Delivery Mode
8.5.6.11. South Africa Market Size and Forecast, by Component
8.5.6.12. South Africa Market Size and Forecast, by End Users
8.5.6.13. Rest of LAMEA Market Size and Forecast, by Product Type
8.5.6.14. Rest of LAMEA Market Size and Forecast, by Delivery Mode
8.5.6.15. Rest of LAMEA Market Size and Forecast, by Component
8.5.6.16. Rest of LAMEA Market Size and Forecast, by End Users

CHAPTER 9: COMPANY PROFILES
9.1. ArisGlobal LLC
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Key strategic moves and developments
9.2. Bioclinica Inc.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Key strategic moves and developments
9.3. Bio-Optronics Inc.
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Key strategic moves and developments
9.4. Forte Research Systems Inc.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Key strategic moves and developments
9.5. IBM Corporation
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. Medidata Solutions Inc.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Business performance
9.6.4. Key strategic moves and developments
9.7. MedNet Solutions Inc.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Key strategic moves and developments
9.8. Oracle Corporation
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. PAREXEL International Corporation
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. Veeva Systems Inc.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Business performance
9.10.4. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Clinical Trial Management Market by Delivery Mode, Product, Component, End Users, and Regionlobal Opportunity Analysis and Industry Forecast, 2017-2023, the global clinical trial management market accounted for $570 million in 2016, and is estimated to reach $1,371 million by 2023, registering a CAGR of 13.4% from 2017 to 2023. North America is the highest contributor in the clinical trial management market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Clinical trial management system (CTMS) helps in the maintenance and management of the vast and highly complex data obtained from clinical trials. The system also tracks the clinical trial occurring in different parts of the word and the data can be analyzed routinely through multiple regression, simulation and other models. In addition, the use of clinical trial management systems helps optimize time management and enhance the connectivity and reduce the communication gap between the researchers and their investors.

The major driving factors for the market growth are surge in the trend of outsourcing of clinical trials and the rise in the number of clinical trials owing to the large demand for novel therapeutic drugs and medical devices. Moreover, the increase in prevalence of chronic diseases and increase in awareness regarding the benefits of using CTM can fuel the growth of the clinical trial management market. In addition, the rise in the expenditure and number of R&D activity by various pharmaceutical companies also help increase the demand for clinical trial management systems. However, high cost associated with CTM and lack of skilled professionals is projected to hamper the market growth.

Among the component, software is the dominant segment in the CTM market due to the availability of advanced software that make improve the efficiency and productivity of the researchers. Web-based has the largest share of the global CTMS market due to the advantages as enhances quality and productivity of clinical trials, better time management, and ease of access.

Enterprise-based system is the dominant segment contributing toward the market growth. However, site-based CTM systems are expected to be fastest growing segment as they are easier to use. Pharmaceutical and biopharmaceutical companies is dominant segment owing to the large number of clinical trials conducted by this segment for the development of novel therapeutic drugs and medical devices.

Key Findings of the Clinical Trial Management Market

Site-based CTM is projected to grow at the highest rate during the analysis period.
North America dominated global clinical trial management market in 2016, and is projected to continue its dominance in future.
China is expected to grow highest in the Asia-Pacific region during the forecast period.
Clinical research organizations is the fastest growing segment among the end user in 2016.
Services segment is expected to be the fastest growing segment during the forecast period.

In 2016, North America was the dominant revenue-generating region, owing to the large number of clinical trials conducted in the region, presence of high disposable income, and high adoption of advanced technology. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to presence of populace countries such as India and China leading to availability of large patient population and rise in healthcare expenditure.

The key players operating in the global clinical trial management market include Oracle, Medidata Solutions, Parexel, BioClinica, Inc., Bio-Optronics, IBM, MedNet Solutions, Veeva Systems, Forte Research Systems, and Merge Healthcare Incorporated. Other prominent players in the value chain include Mednet Solutions, Arisglobal, eClinForce Inc., DZS Software Solutions, DSG, Inc., Guger Technologies Inc., ICON, Plc., ChemWare Inc., and iWeb Technologies Limited.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll